Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

ACI’s 3rd Annual Summit on Life Sciences IP Due Diligence

Date: Thursday, November 14, 2019 7:00 AM - Friday, November 15, 2019 5:30 PM

Venue: OMNI Parker House, Boston, MA

Michael Stern will be speaking on the panel "Understanding the Impact of New Developments at FDA on the IP Due Diligence Review Process" at ACI’s 3rd Annual Summit on Life Sciences IP Due Diligence on November 15, 2019.

For additional information click here.